Mycosis fungoides associated with recurrence of malignant melanoma
Authors:
Open Access
- 1 August 2020
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 6 (8) , 793-795
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4Cancer Research, 2018
- Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III TrialJournal of Clinical Oncology, 2015
- Complete regression of mycosis fungoides after ipilimumab therapy for advanced melanomaJAAD Case Reports, 2015
- CTLA-4 Is a Direct Target of Wnt/β-Catenin Signaling and Is Expressed in Human Melanoma TumorsJournal of Investigative Dermatology, 2008
- Increased Expression of CTLA-4 in Malignant T Cells from Patients with Mycosis Fungoides – Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 2006
- Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndromeInternational Journal of Dermatology, 2003
- HLA-DR5 and DQB1*03 Class II Alleles Are Associated With Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 1996
- HLA‐DQB1*0301 association with increased cutaneous melanoma riskInternational Journal of Cancer, 1994
- Fatal Malignant Melanoma Associated With a Completely Regressed Primary Melanoma in a Patient With Cutaneous T-Cell LymphomaArchives of Dermatology, 1987
- Malignant Melanoma Associated with Mycosis fungoidesDermatology, 1984